Full Breakdown
Non-Invasive Glucose Monitoring: The Promise of the isaac Device
1/17/2026, 9:50:27 PM
Overview of the isaac Device
The isaac device, developed by PreEvnt, represents a significant advancement in non-invasive glucose monitoring technology. Introduced at CES 2025, this small device analyzes breath to detect changes in blood glucose levels by measuring volatile organic compounds, particularly acetone. This approach aims to reduce the discomfort associated with traditional glucose monitoring methods, such as finger pricks and continuous glucose monitors that require skin insertion.
Development and Functionality
The creation of isaac was motivated by the personal experience of inventor Bud Wilcox, whose grandson, Isaac, was diagnosed with type 1 diabetes at two years old. Wilcox collaborated with scientists and engineers, including Dr. M. Agarwal from Indiana University, to develop a device that alerts users to potential glucose events while minimizing the physical and emotional toll of constant testing. Users breathe into the device, which processes the reading and sends data to a companion smartphone app designed for iOS and Android. The app features meal logging, breath reading history, and alerts for emergency contacts, which can be crucial during hypoglycemic events.
Target Audience and Clinical Trials
Isaac is intended for individuals with type 1 and type 2 diabetes, as well as prediabetics and those interested in metabolic health. Currently, the device is undergoing human clinical trials that compare its breath-based alerts to traditional blood glucose monitoring methods. These trials began with adolescents and have since expanded to adults. PreEvnt is pursuing a de novo pathway for regulatory review with the U.S. Food and Drug Administration (FDA), indicating that regulators are showing strong interest in the technology as data from trials continues to emerge.
Implications for Diabetes Management
The potential impact of the isaac device on diabetes management is significant. By providing early alerts for glucose-related changes, it could help users avoid severe complications associated with fluctuating blood sugar levels. This innovation could particularly benefit those who struggle with traditional monitoring methods, such as small children and older adults. If successful in clinical trials and approved by regulators, isaac could reduce the need for frequent finger pricks, making daily life easier and safer for families managing diabetes.
Criticism and Concerns
Despite the promise of the isaac device, some experts express caution regarding its efficacy and reliability compared to traditional glucose monitoring methods. Critics argue that while breath analysis is innovative, it may not yet match the accuracy of established medical-grade glucose meters. Furthermore, the device is still in development and has not yet been made available for sale in the U.S., leaving questions about its long-term viability and acceptance among users.
What's Next for isaac
As clinical trials progress and the FDA review unfolds, the future of the isaac device remains closely watched. If the results continue to be favorable, the device could soon become a viable option for non-invasive glucose monitoring, potentially transforming how individuals with diabetes manage their condition.
Verbatim Quotes
- “The attention around isaac at CES 2026 suggests that promise may finally be getting closer.” — Bud Wilcox, Inventor
- “Early alerts give caregivers or family members a chance to step in.” — PreEvnt Statement
- “Isaac does not claim to replace medical-grade glucose meters.” — PreEvnt Statement
